Atlas Trials

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Clinical trial NCT04853927 · WITHDRAWN

Trial details

NCT number
NCT04853927
Sponsor
Applied Biology, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19SARS (Severe Acute Respiratory Syndrome)
Start date
2021-02-08
Primary completion
2021-10-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.